Flagship Pioneering

Invus

Partners Investment

T. Rowe Price

UPMC Enterprises

Altitude Life Science Ventures

CJ Investment

Alexandria Venture Investments

Kyowa Kirin

Ring Therapeutics

#ICYMI we presented our first NHP data on our #Anellovectors and #AnelloBricks platform at #ESGCT2023. We’re dedicated to revolutionizing the gene therapy and nucleic acid medicine space. Catch up on the data presented here: https://brnw.ch/21wEiKw

Last week, our team took a break from the lab bench and headed out on a city-wide scavenger hunt for a chance to explore our new neighborhood in East Cambridge. Check out these selfies and sites from the competition & congrats to our winners Ashley Tang , Daniel Elliott MBA, SHRM-SCP, Gowtham Akash Jayakumar, Jake Matte, Kavya Atluri, Patricio Jeraldo, and Laurindo Fonseca for taking home the prize during this exciting team bonding activity!

We’ve landed in Brussels for #ESGCT2023! Come stop by and check out our posters showcasing the first NHP transduction data for our #Anellovectors and #AnelloBricks platform. If you can't make it, check out poster details here: https://brnw.ch/21wDRy3

This week, we are presenting new data at the 30th Annual European Society of Gene and Cell Therapy (ESGCT) Conference! Come check out our posters where Geoffrey Parsons will highlight the first NHP transduction data for #Anellovectors and our unique manufacturing approach with #AnelloBricks. Read more about our data here:  https://lnkd.in/eTzKS8td #ESGCT2023

Our #CEO Dr. Tuyen Ong was recently featured in a Genetic Engineering & Biotechnology News article discussing how anelloviruses can address current challenges in genetic medicine and the potential of AnelloVectors from our #Anellogy platform. Read more: https://brnw.ch/21wDorc

At Ring, we're translating the unique biology of commensal anelloviruses into AnelloVectors with our #Anellogy platform.  Learn more about how we're transforming these commensal viruses into life-saving therapies: https://brnw.ch/21wDcIe

We are incredibly proud to be part of Flagship Pioneering as we take bold leaps to tackle challenges in genetic medicine. At Ring, we’re committed to pushing the boundaries of what is possible with our #Anellogy platform. #FlagshipFounded

Today we announced two late-breaking presentations at the 30th Annual European Society of Gene and Cell Therapy (ESGCT) conference in Brussels! Come check out new data from our #Anellogy platform and learn about our unique approach to #genetherapy manufacturing. Read more about our presentation details here: https://brnw.ch/21wCWC7 #ESGCT2023

This summer, we transitioned to a new space to support the growth of our team! This space was meticulously designed to inspire brilliance & collaboration so we can continue pushing boundaries in genetic medicine with our #Anellogy platform. Join us: https://brnw.ch/21wCQrd

#TBT Our CEO Dr. Tuyen Ong chatted with Jonathan Grinstein from Genetic Engineering & Biotechnology News about addressing safety in gene editing and the importance of derisking novel approaches. Click here to read more:  https://fal.cn/3AqY4

Ring Therapeutics is a biotechnology research company based in Cambridge, Massachusetts. Founded in 2017 by Flagship Pioneering, Ring is powering a new era of gene therapy by harnessing the unique biology of commensal anelloviruses. Their research aims to develop anellovirus-based therapies with tissue and cellular tropism, payload versatility, potency, and redosability.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

events

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general	Nov 11, 2024 10:30 AM	f97a2502
crunchbase profile	general
li profile	general	Dec 1, 2023 12:18 AM	0d67513c
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
financials download nd	financials
private financials	financials
customer profile	customers

COM:RINGTX

Ring Therapeutics